Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
29-day randomized double-blind placebo-controlled study of GSK1278863 in hemodialysis-dependent CKD anemia
2015-004790-32Phase 2Completed
- Sponsor
- GSK
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in anemia of renal disease, anaemia and chronic kidney disease (CKD) comparing GSK1278863 TID weekly with Placebo TID weekly (2 arms). Primary endpoint: Change in hemoglobin from baseline at Day 29. Started Jan 2016; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia of renal diseaseanaemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on 2015-004790-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004790-32.